India Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus News Drug Manufacturers Torrent Pharmaceuticals Ltd (BOM:500420) Q2 2025 Earnings Call Highlights: Strong Growth in India and Brazil Amid Operational Challenges
Torrent Pharmaceuticals Ltd (BOM:500420) reports a 9% revenue increase, driven by robust performance in branded businesses and strategic market expansion. Oct 28, 2024
GuruFocus News Drug Manufacturers Q2 2025 Torrent Pharmaceuticals Ltd Earnings Call Transcript
Oct 28, 2024
GuruFocus News Drug Manufacturers Aarti Drugs Ltd (BOM:524348) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Initiatives
Aarti Drugs Ltd (BOM:524348) reports mixed results with promising growth in API volumes and strategic investments amid market challenges. Oct 26, 2024
GuruFocus News Drug Manufacturers Indoco Remedies Ltd (BOM:532612) Q2 2025 Earnings Call Highlights: Navigating Challenges and Celebrating Milestones
Despite facing international revenue declines, Indoco Remedies Ltd (BOM:532612) marks 77 years of excellence and expands its product portfolio. Oct 25, 2024
GuruFocus News Drug Manufacturers Laurus Labs Ltd (BOM:540222) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth Initiatives
Laurus Labs Ltd (BOM:540222) maintains strong gross margins and anticipates growth in its CDMO division despite facing revenue declines in key segments. Oct 25, 2024
GuruFocus News Drug Manufacturers Strides Pharma Science Ltd (BOM:532531) Q2 2025 Earnings Call Highlights: Strong Financial Performance and Strategic Growth Initiatives
Strides Pharma Science Ltd (BOM:532531) reports record EBITDA and robust revenue growth, while navigating challenges in new markets and product launches. Oct 25, 2024
GuruFocus News Drug Manufacturers Q2 2025 Strides Pharma Science Ltd Earnings Call Transcript
Oct 25, 2024
GuruFocus News Drug Manufacturers Earnings To Watch: Glenmark Life Sciences Ltd (BOM:543322) Reports Q2 2025 Result
Oct 24, 2024
GuruFocus News Drug Manufacturers Solara Active Pharma Sciences Ltd (BOM:541540) Q2 2025 Earnings Call Highlights: Record Gross Margin and Strategic Market Focus
Solara Active Pharma Sciences Ltd (BOM:541540) reports significant financial growth and strategic advancements despite ongoing challenges. Oct 22, 2024
GuruFocus News Drug Manufacturers Q2 2025 Solara Active Pharma Sciences Ltd Earnings Call Transcript
Oct 22, 2024
GuruFocus Research Drug Manufacturers Vaishali Pharma Ltd (NSE:VAISHALI) Q3 2024 Earnings Call Transcript Highlights: Strong Financial Performance and Strategic Growth Plans
Vaishali Pharma Ltd (NSE:VAISHALI) reports robust Q3 FY24 results with significant revenue growth and ambitious future targets. Sep 15, 2024
GuruFocus Research Drug Manufacturers Q3 2024 Vaishali Pharma Ltd Earnings Call Transcript
Sep 14, 2024
GuruFocus Research Drug Manufacturers Glenmark Life Sciences Ltd (BOM:543322) Q1 2025 Earnings Call Transcript Highlights: Strong Revenue Growth Amid Margin Pressures
Glenmark Life Sciences Ltd (BOM:543322) reports a 9.7% increase in revenue and a 14.1% rise in EBITDA for Q1 FY25, despite facing challenges in gross margins and regulatory issues. Sep 13, 2024
GuruFocus Research Drug Manufacturers Glenmark Life Sciences Ltd (BOM:543322) (FY24) Earnings Call Transcript Highlights: Strong Revenue Growth Amid Supply Chain Challenges
Glenmark Life Sciences Ltd (BOM:543322) reports a 5.6% revenue growth for FY24, despite geopolitical issues impacting supply chains. Sep 13, 2024
GuruFocus Research Drug Manufacturers Suven Pharmaceuticals Ltd (BOM:543064) Q1 2025 Earnings Call Transcript Highlights: Key Financial Metrics and Strategic Insights
Despite a revenue decline, Suven Pharmaceuticals Ltd (BOM:543064) shows strong margins and positive growth outlook for H2 FY25. Sep 13, 2024
GuruFocus Research Drug Manufacturers Q1 2025 Glenmark Life Sciences Ltd Earnings Call Transcript
Sep 13, 2024
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers